Korea’s Health Ministry Selects 43 Innovative Companies For Tax/Funding Benefits
This article was originally published in PharmAsia News
Executive Summary
Tax credits, priority for government projects and expanded funding opportunities will support 42 Korean firms and Korea-heavy Otsuka Pharmaceutical with R&D expansion